Highlights Nieuwsbrief 2

Deze nieuwsbrief presenteert u de volgende lezingen:

1. Podcast with Manish R. Patel, DO, about the efficacy and safety of entrectinib in NTRK fusion-positive
    gastrointestinal cancers

2. Also older patients with previously untreated unresectable hepatocellular carcinoma derive more clinical
    benefit from atezolizumab-bevacizumab compared to sorafenib

3. Perioperative systemic therapy: feasible, safe and tolerable in patients with isolated colorectal peritoneal
    metastases

4. Confirmed clinical efficacy of nivolumab in a real-world population of advanced gastric cancer patients

5. Pembrolizumab may potentiate subsequent therapy in patients with advanced gastric or
    gastroesophageal junction adenocarcinoma